Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 18/20 | 0.56 |
| ▸ | MET | P08581 | 1/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.44 |
| ▸ | INSR | P06213 | 1/20 | 0.43 |
| ▸ | IGF1R | P08069 | 1/20 | 0.43 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30860759 | 0.96 | EGFR (0.56) | EGFRMETBTK | |
| SCHEMBL30860330 | 0.93 | EGFR (0.66) | EGFRMETPLK1BTKINSR | |
| SCHEMBL30860746 | 0.92 | EGFR (0.54) | EGFRMETPLK1BTK | |
| SCHEMBL25001448 | 0.92 | EGFR (0.58) | EGFRMETPLK1BTKINSR | |
| SCHEMBL30860320 | 0.90 | EGFR (0.58) | EGFRPLK1BTK | |
| SCHEMBL30860266 | 0.89 | EGFR (0.60) | EGFRMETBTKINSRIGF1R | |
| SCHEMBL30860245 | 0.89 | EGFR (0.58) | EGFRMETINSRIGF1RALK | |
| SCHEMBL30860338 | 0.89 | EGFR (0.61) | EGFRMET | |
| SCHEMBL30860400 | 0.88 | EGFR (0.54) | EGFRMETPLK1INSRIGF1R | |
| SCHEMBL30860273 | 0.87 | EGFR (0.53) | EGFRMETBTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024072075-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2024-04-04 | — | — | WO | claimed |
| WO-2024072075-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2024-04-04 | — | — | WO | disclosed |